Ian D. Collier

557 total citations
19 papers, 448 citations indexed

About

Ian D. Collier is a scholar working on Oncology, Molecular Biology and Biochemistry. According to data from OpenAlex, Ian D. Collier has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Biochemistry. Recurrent topics in Ian D. Collier's work include Drug Transport and Resistance Mechanisms (11 papers), Amino Acid Enzymes and Metabolism (9 papers) and Chemical Synthesis and Analysis (6 papers). Ian D. Collier is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Amino Acid Enzymes and Metabolism (9 papers) and Chemical Synthesis and Analysis (6 papers). Ian D. Collier collaborates with scholars based in United Kingdom, United States and Japan. Ian D. Collier's co-authors include Patrick D. Bailey, Keith M. Morgan, C.A.R. Boyd, David Meredith, Catherine S. Temple, J. R. Bronk, Norma Lister, Richard D. Vaughan‐Jones, David R. Adams and Andrew K. Stewart and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Ian D. Collier

19 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian D. Collier United Kingdom	12	235	192	122	106	53	19	448
Chao‐Pin Lee United States	12	179 0.8×	131 0.7×	61 0.5×	41 0.4×	42 0.8×	16	368
Catherine S. Temple United Kingdom	7	244 1.0×	150 0.8×	133 1.1×	13 0.1×	67 1.3×	10	350
Roberto Nuti Italy	11	165 0.7×	304 1.6×	21 0.2×	93 0.9×	12 0.2×	16	628
Stephan Kopp Austria	13	438 1.9×	252 1.3×	16 0.1×	45 0.4×	156 2.9×	24	698
Masaharu Hirata Japan	13	46 0.2×	287 1.5×	63 0.5×	109 1.0×	12 0.2×	35	514
Emiliano Rosatelli Italy	10	265 1.1×	170 0.9×	12 0.1×	101 1.0×	19 0.4×	13	486
Anthony L. Handlon United States	14	97 0.4×	234 1.2×	11 0.1×	191 1.8×	11 0.2×	20	502
Alexandre Pozza France	10	274 1.2×	284 1.5×	16 0.1×	22 0.2×	73 1.4×	18	522
Andrea M. Sefler United States	11	72 0.3×	460 2.4×	36 0.3×	191 1.8×	8 0.2×	18	684
Frank Navas United States	14	206 0.9×	253 1.3×	9 0.1×	209 2.0×	10 0.2×	20	586

Countries citing papers authored by Ian D. Collier

Since Specialization

Citations

This map shows the geographic impact of Ian D. Collier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian D. Collier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian D. Collier more than expected).

Fields of papers citing papers by Ian D. Collier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian D. Collier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian D. Collier. The network helps show where Ian D. Collier may publish in the future.

Co-authorship network of co-authors of Ian D. Collier

This figure shows the co-authorship network connecting the top 25 collaborators of Ian D. Collier. A scholar is included among the top collaborators of Ian D. Collier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian D. Collier. Ian D. Collier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Johnston, Karen, Zhong‐Tao Jiang, Ian D. Collier, et al.. (2007). Concise routes to pyrazolo[1,5-a]pyridin-3-yl pyridazin-3-ones. Organic & Biomolecular Chemistry. 6(1). 175–186. 27 indexed citations

Hsueh, Eddy C., et al.. (2006). Recombinant arginase as a novel anti-melanoma agent. Journal of Clinical Oncology. 24(18_suppl). 12032–12032. 1 indexed citations

Bailey, Patrick D., C.A.R. Boyd, Ian D. Collier, et al.. (2005). Conformational and spacial preferences for substrates of PepT1. Chemical Communications. 5352–5352. 8 indexed citations

Bailey, Patrick D., C.A.R. Boyd, Ian D. Collier, et al.. (2005). Affinity prediction for substrates of the peptide transporter PepT1. Chemical Communications. 323–325. 20 indexed citations

Bailey, Patrick D., C.A.R. Boyd, Ian D. Collier, et al.. (2005). Probing dipeptide trans/cis stereochemistry using pH control of thiopeptide analogues, and application to the PepT1 transporter. Organic & Biomolecular Chemistry. 3(22). 4038–4038. 13 indexed citations

Lister, Norma, Julie Affleck, J. R. Bronk, et al.. (2002). Identification of a candidate membrane protein for the basolateral peptide transporter of rat small intestine. Biochemical and Biophysical Research Communications. 296(4). 918–922. 12 indexed citations

Bailey, Patrick D., et al.. (2001). A concise, efficient route to fumitremorgins. Tetrahedron Letters. 42(1). 113–115. 25 indexed citations

Bailey, Patrick D., C.A.R. Boyd, J. R. Bronk, et al.. (2000). How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1. Angewandte Chemie International Edition. 39(3). 505–508. 91 indexed citations

Meredith, David, Catherine S. Temple, Nishan Guha, et al.. (2000). Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1. European Journal of Biochemistry. 267(12). 3723–3728. 61 indexed citations

10.

Bailey, Patrick D., C.A.R. Boyd, J. R. Bronk, et al.. (2000). How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1. Angewandte Chemie. 112(3). 515–518. 6 indexed citations

11.

Bailey, Patrick D., C.A.R. Boyd, J. R. Bronk, et al.. (2000). ChemInform Abstract: How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1.. ChemInform. 31(16). 1 indexed citations

12.

Temple, Catherine S., et al.. (1998). Structural Requirements for Non-peptide substrate Binding to the Epithelial proton-Coupled Oligopeptide Transporter. The Journal of Physiology. 26–27. 1 indexed citations

13.

Temple, Catherine S., Andrew K. Stewart, David Meredith, et al.. (1998). Peptide Mimics as Substrates for the Intestinal Peptide Transporter. Journal of Biological Chemistry. 273(1). 20–22. 75 indexed citations

14.

Meredith, David, C.A.R. Boyd, J. R. Bronk, et al.. (1998). 4‐Aminomethylbenzoic acid is a non‐translocated competitive inhibitor of the epithelial peptide transporter PepT1. The Journal of Physiology. 512(3). 629–634. 44 indexed citations

15.

Lister, Norma, Patrick D. Bailey, Ian D. Collier, C.A.R. Boyd, & J. R. Bronk. (1997). The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitro. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1324(2). 245–250. 12 indexed citations

16.

Bailey, Patrick D., Ian D. Collier, Sean P. Hollinshead, et al.. (1997). New asymmetric route to bridged indole alkaloids: formal enantiospecific syntheses of (−)-suaveoline, (−)-raumacline and (−)-N b-methylraumacline. Journal of the Chemical Society Perkin Transactions 1. 1209–1214. 15 indexed citations

17.

Adams, David R., et al.. (1996). An efficient route to the α-methyl ester ofL-glutamic acid, and its conversion into cis-5-hydroxy-L-pipecolic acid. Chemical Communications. 349–350. 19 indexed citations

18.

Adams, David R., et al.. (1996). The mechanism for the rearrangement of the adamantly cation. Chemical Communications. 333–333. 7 indexed citations

19.

Bailey, Patrick D., Ian D. Collier, Sean P. Hollinshead, et al.. (1994). A new asymmetric route to bridged indole alkaloids: formal syntheses of (–)-suaveoline, (–)-raumacline and (–)-N^b-methylraumacline. Journal of the Chemical Society Chemical Communications. 1559–1560. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact